Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 24.01 % |
3 Month Return | + 20.67 % |
1 Year Return | + 25.56 % |
Market Stats | |
Previous Close | ₹289.35 |
Open | ₹283.50 |
Volume | 75.00K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹356.03Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹356.03 Cr |
P/B Ratio | 3.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 18.49 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹356.03 Cr | 234.37% | 0.50 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | Par Drugs & Chemicals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd has seen an excellent gain of 29% in the last month, bringing the annual gain to a sharp 78%. The company's strong earnings performance may have repressed the P/E, but if it continues, existing shareholders can be optimistic about future share price direction.
Par Drugs & Chemicals Ltd Shows Strong Growth Potential - 05 Apr, 2024
Par Drugs & Chemicals Ltd has shown consistent growth in EPS, EBIT margins, and revenues. With insiders holding 78% of the company, it's a stock worth following for potential investment opportunities.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, PAR stock has moved up by 6.7%
Retail Holding Up
Retail Investor have increased holdings from 25.47% to 26.54% in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 33.0%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 67.8%
FII Holding Down
Foreign Institutions have decreased holdings from 0.32% to 0.09% in Sep 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 74.21% to 73.37% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 73.37% | ||
Foreign Institutions | 0.09% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.54% | 4.22 | |
Others | 0% | 0.00 |
Par Drugs & Chemicals Ltd’s net profit jumped 75.87% since last year same period to ₹8.60Cr in the Q2 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 239.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.43%.
Read More about DividendsBearish
Neutral
Bullish
Par Drugs & Chemicals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Par Drugs & Chemicals Ltd (PAR) share price today is ₹281.4
Par Drugs & Chemicals Ltd is listed on NSE
Par Drugs & Chemicals Ltd is not listed on BSE
Today’s traded volume of Par Drugs & Chemicals Ltd(PAR) is 75.00K.
Today’s market capitalisation of Par Drugs & Chemicals Ltd(PAR) is ₹356.03Cr.
Par Drugs & Chemicals Ltd(PAR | Price |
---|---|
52 Week High | ₹325 |
52 Week Low | ₹190.15 |
Par Drugs & Chemicals Ltd(PAR) share price is ₹281.4. It is down -13.42% from its 52 Week High price of ₹325
Par Drugs & Chemicals Ltd(PAR) share price is ₹281.4. It is up 47.99% from its 52 Week Low price of ₹190.15
Par Drugs & Chemicals Ltd(PAR | Returns |
---|---|
1 Day Returns | -7.95% |
1 Month Returns | 24.01% |
3 Month Returns | 20.67% |
1 Year Returns | 25.56% |